MedicQuant

MedicQuant is a Danish MedTech company developing rapid diagnostics for acute stroke care. The company’s first product is designed to help doctors quickly measure the level of blood thinners in patients with suspected stroke. This addresses a critical challenge in emergency medicine, where every 15 minutes of delay increases mortality by 4 percent and disability by 7 percent, while current lab testing can take around one hour.

MedicQuant’s solution is built to bring answers closer to the patient by delivering results from whole blood in under 10 minutes. The company is initially focused on stroke care, where faster answers can help clinicians make treatment decisions sooner, reduce complications and improve the use of hospital resources. Over time, the platform has the potential to be used for other urgent care needs and additional drug measurements.

MedicQuant is a research-driven company originating from iNANO at Aarhus University. The team is led by CEO & Co-founder Line Nielsen and CTO & Co-founder Malthe Hansen-Bruhn, who combine deep scientific expertise with a strong understanding of how to turn research into a product that can create real clinical impact. Together with the broader team, they are building a company focused on solving urgent problems in some of healthcare’s most time-critical settings.

Key facts

• Danish MedTech company
• Rapid diagnostics for acute stroke care
• First product focused on measuring blood thinner levels in suspected stroke patients
• Results from whole blood in under 10 minutes
• Research-driven company originating from iNANO at Aarhus University

Team

• Line Nielsen, CEO & Co-founder
• Malthe Hansen-Bruhn, CTO & Co-founder
• Jeppe Dehli, Director of Hardware Developmen